Zenlabs Ethica — 360° view

Zenlabs Ethica, a company in the Diversified Commercial Services industry, reported revenue of ₹11 crore and a net loss of ₹0.09 crore for the September 2026 quarter.

Zenlabs Ethica (BSE: ZENLABS) closed at ₹28.00 on 20 Nov 2026, down 8.2% over the past year. Its market capitalisation is ₹18 crore.

Share price
₹28.00 (20 Nov 2026)
Market cap
₹18 Cr (20 Nov 2026)
Revenue
₹11 Cr (September 2026 quarter)
Net profit
₹-0 Cr (September 2026 quarter)
ROCE
5.07% (FY26)
ROE
0.21% (FY26)
Book value
₹12.1 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹39.99 / ₹16.50 (20 Nov 2026)
1-year return
-8.2% (to 20 Nov 2026)
Sector
Services
Industry
Diversified Commercial Services
Symbol
BSE: ZENLABS

Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.